Giovanni Pellacani

25.5k total citations
651 papers, 14.0k citations indexed

About

Giovanni Pellacani is a scholar working on Oncology, Dermatology and Epidemiology. According to data from OpenAlex, Giovanni Pellacani has authored 651 papers receiving a total of 14.0k indexed citations (citations by other indexed papers that have themselves been cited), including 348 papers in Oncology, 339 papers in Dermatology and 208 papers in Epidemiology. Recurrent topics in Giovanni Pellacani's work include Cutaneous Melanoma Detection and Management (318 papers), Nonmelanoma Skin Cancer Studies (176 papers) and Optical Coherence Tomography Applications (120 papers). Giovanni Pellacani is often cited by papers focused on Cutaneous Melanoma Detection and Management (318 papers), Nonmelanoma Skin Cancer Studies (176 papers) and Optical Coherence Tomography Applications (120 papers). Giovanni Pellacani collaborates with scholars based in Italy, United States and Spain. Giovanni Pellacani's co-authors include Caterina Longo, Stefania Seidenari, Anna Maria Cesinaro, Giuseppe Argenziano, Francesca Farnetani, Pascale Guitera, Iris Zalaudek, Scott W. Menzies, Costantino Grana and Alice Casari and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Giovanni Pellacani

618 papers receiving 13.7k citations

Peers

Countries citing papers authored by Giovanni Pellacani

Since Specialization

Citations

This map shows the geographic impact of Giovanni Pellacani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giovanni Pellacani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giovanni Pellacani more than expected).

Fields of papers citing papers by Giovanni Pellacani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giovanni Pellacani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giovanni Pellacani. The network helps show where Giovanni Pellacani may publish in the future.

Co-authorship network of co-authors of Giovanni Pellacani

This figure shows the co-authorship network connecting the top 25 collaborators of Giovanni Pellacani. A scholar is included among the top collaborators of Giovanni Pellacani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giovanni Pellacani. Giovanni Pellacani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Systematic Review and Meta-Analysis of Ocular and Periocular Basal Cell Carcinoma with First-Time Description of Dermoscopic and Reflectance Confocal Microscopy Features of Caruncle Basal Cell Carcinoma 2025 ·Diagnostics ·(unknown), Shaniko Kaleci, Pasquale Frascione, (unknown), Maria Concetta Fargnoli, Giovanni Pellacani, Victor Desmond Mandel	0
2	Passive versus active educational interventions for nevus and melanoma classification: A randomized controlled study 2025 ·Journal of the European Academy of Dermatology and Venereology ·(unknown), Riccardo Pampena, Ketty Peris, Laura Del Regno, (unknown), Maria Concetta Fargnoli, Cristina Pellegrini, Pietro Quaglino, Simone Ribero, Piergiacomo Calzavara‐Pinton, (unknown), M. Mirra, Margherita Raucci, Andrea Fusco, Shaniko Kaleci, Johanna Chester, Giovanni Pellacani, Caterina Longo	0
3	Concordance Among In-Vivo Reflectance Confocal Microscopy, Trichoscopy, and Histopathology in the Evaluation of Alopecia Areata Incognita 2024 ·Dermatology Practical & Conceptual ·(unknown), Nathalie De Carvalho, Daniel Fernandes Melo, (unknown), Victor Desmond Mandel, Carla Jorge Machado, Cosimo Misciali, Giovanni Pellacani, Bianca Maria Piraccini, Marco Ardigò	1
4	OPT-In; Optimized Patient Treatment Outcomes in Plaque Psoriasis: A 3-Year State-Transition Treatment-Sequencing Model in the Italian Setting 2024 ·Dermatology and Therapy ·(unknown), Nicoletta Bernardini, Martina Burlando, Antonio Costanzo, (unknown), (unknown), Francesco Loconsole, Matteo Megna, Giovanni Pellacani, Stefano Piaserico, Francesca Prignano, (unknown), Nevena Skroza, (unknown)	0
5	Clinical and Ultrasound Efficacy of Topical Hypertonic Cream (Jovita Osmocell®) in the Treatment of Cellulite: A Prospective, Monocentric, Double-Blind, Placebo-Controlled Study 2024 ·Medicina ·(unknown), (unknown), Vito Cantisani, (unknown), (unknown), Giovanni Rossi, (unknown), (unknown), Giovanni Paolino, Luigi Losco, (unknown), Elena Campione, Luca Bianchi, Steven Paul Nisticò, Giovanni Pellacani, Carmen Cantisani	2
6	Diagnostic Imaging of Agminated Blue Lesions and Blue Lesions with Satellitosis: Case Series with a Concise Review of the Current Literature 2024 ·Journal of Clinical Medicine ·Carmen Cantisani, Giovanni Paolino, (unknown), Vito Gomes, Andrea Carugno, (unknown), (unknown), (unknown), Giovanni Rossi, G. Soda, Caterina Longo, Giovanni Pellacani	0
7	Efficacy and safety of tirbanibulin 1% ointment in actinic keratoses: Data from two phase‐III trials and the real‐life clinical practice presented at the European Academy of Dermatology and Venereology Congress 2022 2023 ·Journal of the European Academy of Dermatology and Venereology ·Giovanni Pellacani, Tobias Schlesinger, Neal Bhatia, Brian Berman, Mark Lebwohl, Jerald L. Cohen, Girish K. Patel, Rainer Kunstfeld, Ina Hadshiew, John T. Lear	5
8	Efficacy and Microbiota Modulation Induced by LimpiAL 2.5%, a New Medical Device for the Inverse Psoriasis Treatment 2023 ·International Journal of Molecular Sciences ·Laura Pietrangelo, Annunziata Dattola, (unknown), Giulio Petronio Petronio, (unknown), (unknown), (unknown), Andreas Wollenberg, Giovanni Pellacani, Roberto Di Marco	3
9	Long-term strategies for management of advanced basal cell carcinoma with hedgehog inhibitors 2023 ·Critical Reviews in Oncology/Hematology ·Paolo Bossi, Paolo A. Ascierto, Nicole Basset‐Séguin, Brigitte Dréno, Reinhard Dummer, Axel Hauschild, Peter Mohr, Roland Kaufmann, Giovanni Pellacani, Susana Puig, D. Moreno‐Ramírez, Caroline Robert, (unknown), Ralf Gutzmer, Paola Queirolo, Pietro Quaglino, Ketty Peris	21
10	Activation of cGMP-Dependent Protein Kinase Restricts Melanoma Growth and Invasion by Interfering with the EGF/EGFR Pathway 2021 ·Journal of Investigative Dermatology ·(unknown), Antonella Comitato, Elisabetta Palazzo, Natascia Tiso, Andreas Rentsch, Giovanni Pellacani, Alessandra Marconi, Valeria Marigo	13
11	Segmentation of cellular patterns in confocal images of melanocytic lesions in vivo via a multiscale encoder-decoder network (MED-Net) 2020 ·IRIS UNIMORE (University of Modena and Reggio Emilia) ·Kıvanç Köse, Alican Bozkurt, Christi Alessi‐Fox, Melissa Gill, Caterina Longo, Giovanni Pellacani, Jennifer Dy, Dana H. Brooks, Milind Rajadhyaksha	22
12	Basal cell carcinoma or melanoma, that is the question! 2020 ·Journal of the European Academy of Dermatology and Venereology ·Riccardo Pampena, Michela Lai, Simonetta Piana, Giovanni Pellacani, Caterina Longo	1
13	Microscopic and functional changes observed with dynamic optical coherence tomography for severe refractory atopic dermatitis treated with dupilumab 2020 ·Skin Research and Technology ·Marco Manfredini, (unknown), Silvana Ciardo, Laura Bonzano, (unknown), Johanna Chester, Shaniko Kaleci, Giovanni Pellacani	22
14	In vivo confocal microscopy: The role of comparative approach in patients with multiple atypical nevi 2020 ·Experimental Dermatology ·(unknown), Riccardo Pampena, Stefania Guida, Barbara De Pace, Silvana Ciardo, Johanna Chester, Caterina Longo, Francesca Farnetani, Giovanni Pellacani	3
15	Management of long-term therapy with biological drugs in psoriatic patients with latent tuberculosis infection in real life setting 2017 ·Dermatologic Therapy ·Andrea Conti, Stefano Piaserico, Paolo Gisondi, Giulia Odorici, Giovanna Galdo, Claudia Lasagni, Giovanni Pellacani	11
16	Pseudoxanthoma elasticum and reflectance confocal microscopy. report of two affected young sisters 2015 ·SHILAP Revista de lepidopterología ·Victor Desmond Mandel, Federica Boraldi, Giovanni Pellacani, Silvana Ciardo, (unknown), Francesca Farnetani	4
17	Physicians' concerns towards prescription adherence and treatment effectiveness in the clinical management of actinic keratosis. 2014 ·PubMed ·Ketty Peris, Luca Neri, Maria Concetta Fargnoli, Giovanni Pellacani	5
18	Relapsed actinic keratosis evaluation: an observational Italian multicenter prospective study. Does gender have a role? 2014 ·PubMed ·Sanja Javor, Sergio Chimenti, Annalisa Patrizi, Luca Stingeni, Giovanni Pellacani, S. Cavicchini, R. Sala, Franco Rongioletti, Aurora Parodi	3
19	Physicians' opinions and clinical practice patterns for actinic keratosis management in Italy. 2014 ·PubMed ·Ketty Peris, Luca Neri, Piergiacomo Calzavara‐Pinton, Caterina Catricalà, Giovanni Pellacani, Nicola Pimpinelli, Andrea Peserico	5
20	Key Opinion Leader (KOL) Consensus for actinic keratosis management in Italy: the AKTUAL Workshop. 2013 ·PubMed ·Andrea Peserico, Luca Neri, Piergiacomo Calzavara‐Pinton, Caterina Catricalà, Giovanni Pellacani, Ketty Peris, Nicola Pimpinelli	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact